Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
p4pVwYBwZHGmHjC5
